Carl Decicco
President bei Adnexus
Profil
Carl Peter Decicco is currently the Director at Cellarity Inc. and the President at Adnexus.
He was previously the Independent Non-Executive Director at Syngene International Ltd.
from 2019 to 2023, Senior VP-Research & Head-Discovery at Bristol Myers Squibb Co. from 2013 to 2018, and Chief Scientific Officer at Foghorn Therapeutics, Inc. from 2018 to 2022.
He also worked as an Advisor Partner at Flagship Pioneering.
Decicco received his graduate degree from Harvard University in 1990 and his doctorate from the University of Guelph in 1988.
He also received his undergraduate degree from the University of Guelph.
Aktive Positionen von Carl Decicco
| Unternehmen | Position | Beginn |
|---|---|---|
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | President | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Carl Decicco
| Unternehmen | Position | Ende |
|---|---|---|
| SYNGENE INTERNATIONAL LIMITED | Director/Board Member | 25.10.2023 |
| FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 10.01.2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 01.11.2018 |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - |
Ausbildung von Carl Decicco
| Harvard University | Graduate Degree |
| University of Guelph | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| SYNGENE INTERNATIONAL LIMITED | Commercial Services |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Flagship Pioneering
Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
